An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Karuna Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Karuna Therapeutics (NASDAQ: KRTX) announced presentations at upcoming virtual investor conferences to discuss their innovative treatments for psychiatric and neurological conditions. Key events include the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, the 1st Annual Needham Virtual Neuroscience Forum on March 16, 2022, and the Stifel 2022 CNS Days on March 28, 2022, with respective times at 9:20 a.m. ET, 11:00 a.m. ET, and 1:30 p.m. ET.
A live webcast of these events will be available on their website.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will present at the following upcoming virtual investor conferences:
Oppenheimer 32nd Annual Healthcare Conference
Date: Tuesday, March 15, 2022 Time: 9:20 a.m. ET
1st Annual Needham Virtual Neuroscience Forum Date: Wednesday, March 16, 2022 Time: 11:00 a.m. ET
Stifel 2022 CNS Days
Date: Monday, March 28, 2022 Time: 1:30 p.m. ET
A live webcast of the presentations will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the conference.
About Karuna Therapeutics Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.